Literature DB >> 1357359

High concentrations of the interleukin-1 receptor antagonist in serum of patients with Hodgkin's disease.

H J Gruss, G Dölken, M A Brach, R Mertelsmann, F Herrmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1357359     DOI： 10.1016/0140-6736(92)92849-b

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Multiple sclerosis: longitudinal measurement of interleukin-1 receptor antagonist.

Authors:  R Voltz; M Hartmann; S Spuler; A Scheller; N Mai; R Hohlfeld; T Yousry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

2.  Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis.

Authors:  J Arondel; M Singer; A Matsukawa; A Zychlinsky; P J Sansonetti
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Early induction of IL-1 receptor antagonist (IL-1Ra) in infants and children undergoing surgery.

Authors:  E M O Nualláin; P Puri; D J Reen
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

4.  Serum levels of interleukin-1 receptor antagonist (IL-1ra) in thyroid cancer patients.

Authors:  Sebastian Niedźwiecki; Tomasz Stepień; Krzysztof Kuzdak; Henryk Stepień; Roman Krupiński; Daniel Seehofer; Nada Rayes; Frank Ulrich
Journal:  Langenbecks Arch Surg       Date:  2007-12-07       Impact factor: 3.445

5.  Preferential production of interleukin-1 beta over interleukin-1 receptor antagonist contributes to proliferation and suppression of apoptosis in leukemic cells.

Authors:  Y Furukawa; J Kikuchi; Y Terui; S Kitagawa; M Ohta; Y Miura; M Saito
Journal:  Jpn J Cancer Res       Date:  1995-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.